Using K-TRACS can help inform clinical decisions as you work to improve patient safety and promote community health. Prescribers can use K-TRACS before prescribing controlled substances to identify overlapping or duplicative prescriptions from other prescribers as well as any prescription drug patterns. K-TRACS patient information should be used in combination with a patient's health history and other factors to assist with clinical decision-making.
The Kansas Medicaid program requires Medicaid-enrolled providers to check K-TRACS prior to prescribing controlled substances for Medicaid members. All other use of K-TRACS is voluntary; there are no state mandates in Kansas.
K-TRACS offers continuing education opportunities for prescribers to learn more about using K-TRACS to improve patient outcomes and about prescribing best practices, including the 2022 CDC Clinical Practice Guidelines for Opioid Prescribing for Pain.
Three-fourths of K-TRACS users are prescribers and their delegates. The number of active prescriber users, including delegates, increased 14% in 2022.
Prescribers and their delegates completed over two-thirds of all patient searches in 2022. The number of patient searches completed by prescribers and their delegates increased 65% in 2022.
View a variety of prescribing resources and best practices from CDC, CMS and other regulatory agencies. Review relevant resources with all prescribers in your practice or department to ensure consistency in prescribing.
The most effective screening tool for substance use disorders is SBIRT, Screening, Brief Intervention and Referral to Treatment.
The screening quickly assesses the risk of a substance use disorder and identifies the appropriate level of treatment. The brief intervention focuses on patients understanding their substance use, health impact and motivations for behavior change. The referral provides patients with access to appropriate specialty care.